Interdisciplinary Oncology - Doctor of Philosophy - PHD - Postgraduate / Graduate Program - UBC Grad School

Canadian Immigration Updates

Review details about the recently announced changes to study and work permits that apply to master’s and doctoral degree students. Read more

Notice: Canadian Immigration Updates

Go to programs search

Overview

The Interdisciplinary Oncology program (IOP) is a graduate program designed to appeal to a broad range of students interested in cancer research. IOP offers advanced study and research in a variety of fields relating to oncology. Those fields include: molecular and cellular biology, genetics, biophysics, bioinformatics, pharmaceutical sciences, radiological sciences, immunology, molecular pathology, sociobehavioral studies, epidemiology and health economics. The goal of the program is to provide graduate students from diverse backgrounds, with an education in a number of disciplines relating to oncology, and to provide training opportunities for intensive training in specialized aspects of cancer research. For more than ten years, the program has been training the next generation of cancer research leaders.

For specific program requirements, please refer to the departmental program website

$25,105

Net funding per year^*

Average years to completion

What makes the program unique?

IOP integrates the diverse areas of oncology by offering two required courses which provide an interdisciplinary perspective on oncology in a form that is accessible to students from diverse backgrounds. The elective courses provide intensive training in one or more subjects specific to the student's research, and also gives the student an opportunity to gain expertise in other disciplines that have potential for synergy with their primary specialization. Students have access to clinicians and university faculty through the world-renowned BC Cancer Agency, to get a practical perspective on oncology treatments and outcomes. An innovative rotation course is a unique option for students to gain hands-on experience by rotating through specialty laboratories and by shadowing clinicians.

What drew me to the IOP was its commitment to comprehensive study, collaboration, and innovation, which offers the flexibility to tailor my education to align with my specific research goals.

Ariene Cabantog

Quick Facts

Faculty Faculty of Medicine

Academic Unit Division of Medical Oncology

Specialization Interdisciplinary Oncology

Mode of delivery In person at UBC Vancouver

Program Components

Dissertation

Tuition (First Year) Domestic: $5,626.02 | International: $9,883.98

Median Funding 50% of students receive $33,392 or more funding per year in the first 4 years, before tuition and fees

Information Sessions Register

Apply Now

Apply for January 2026

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.

Apply for May 2026

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.

Apply for September 2026

If you don't have a UBC Campus-Wide Login (CWL) please create an account first.

Open All

Admission Information & Requirements

Program Instructions

Students must secure a supervisor before they can be admitted into the program. As well, they must meet the minimum admission requirements set out by Graduate and Post-doctoral Studies at UBC.

1) Check Eligibility

Minimum Academic Requirements

The Faculty of Graduate and Postdoctoral Studies establishes the minimum admission requirements common to all applicants, usually a minimum overall average in the B+ range (76% at UBC). The graduate program that you are applying to may have additional requirements. Please review the specific requirements for applicants with credentials from institutions in:

Each program may set higher academic minimum requirements. Please review the program website carefully to understand the program requirements. Meeting the minimum requirements does not guarantee admission as it is a competitive process.

English Language Test

Applicants from a university outside Canada in which English is not the primary language of instruction must provide results of an English language proficiency examination as part of their application. Tests must have been taken within the last 24 months at the time of submission of your application.

Minimum requirements for the two most common English language proficiency tests to apply to this program are listed below:

TOEFL: Test of English as a Foreign Language - internet-based

Overall score requirement: 100

Reading

Writing

Speaking

Listening

IELTS: International English Language Testing System

Overall score requirement: 7.5

Reading

7.0

Writing

7.0

Speaking

7.0

Listening

7.0

Other Test Scores

Some programs require additional test scores such as the Graduate Record Examination (GRE) or the Graduate Management Test (GMAT). The requirements for this program are:

The GRE is not required.

Prior degree, course and other requirements

Prior Degree Requirements

A B.Sc is the minimum requirement.

Document Requirements

Transcript Deadline: 15 December 2026

Referee Deadline: 30 December 2026

Deadline Explanations

Application Deadline

Deadline to submit online application. No changes can be made to the application after submission.

Transcript Deadline

Deadline to upload scans of official transcripts through the applicant portal in support of a submitted application. Information for accessing the applicant portal will be provided after submitting an online application for admission.

Referee Deadline

Deadline for the referees identified in the application for admission to submit references. See Letters of Reference for more information.

3) Prepare Application

Transcripts

All applicants have to submit transcripts from all past post-secondary study. Document submission requirements depend on whether your institution of study is within Canada or outside of Canada.

Letters of Reference

A minimum of two references are required for application to graduate programs at UBC. Each graduate program determines the type of reference (e.g. academic, professional) and number of references they require which can range from 2 to 4. References should be requested from individuals who are prepared to provide a report on your qualifications for the program.

Statement of Interest

Many programs require a statement of interest, sometimes called a "statement of intent", "description of research interests" or something similar.

Supervision

Students in research-based programs usually require a faculty member to function as their thesis supervisor. Please follow the instructions provided by each program whether applicants should contact faculty members.

Instructions regarding thesis supervisor contact for Doctor of Philosophy in Interdisciplinary Oncology (PhD)

All applicants need firm commitment from a supervisor prior to applying.

Citizenship Verification

Permanent Residents of Canada must provide a clear photocopy of both sides of the Permanent Resident card.

4) Apply Online

All applicants must complete an online application form and pay the application fee to be considered for admission to UBC.

Research Information

Program Components

Once students are enrolled in the program, they will have an opportunity to design a program that allows for rotations through other IOP faculty's labs to gain insight into other research areas other than their specific supervisor's research.

Research Facilities

Most IOP supervisors reside off-campus at the BC Cancer Research Centre, the Prostate Centre at Vancouver General Hospital or other hospital-related buildings.

Tuition & Financial Support

Tuition

Fees	Canadian Citizen / Permanent Resident / Refugee / Diplomat	International
Application Fee	$116.25	$168.25
Tuition *
Installments per year	3	3
Tuition per installment	$1,875.34	$3,294.66
Tuition per year (plus annual increase, usually 2%-5%)	$5,626.02	$9,883.98
Int. Tuition Award (ITA) per year (if eligible)		$3,200.00 (-)
Other Fees and Costs
Student Fees (yearly)	$1,144.10 (approx.)
Costs of living	Estimate your costs of living with our interactive tool in order to start developing a financial plan for your graduate studies.

* Regular, full-time tuition. For on-leave, extension, continuing or part time (if applicable) fees see UBC Calendar.
All fees for the year are subject to adjustment and UBC reserves the right to change any fees without notice at any time, including tuition and student fees. Tuition fees are reviewed annually by the UBC Board of Governors. In recent years, tuition increases have been 2% for continuing domestic students and between 2% and 5% for continuing international students. New students may see higher increases in tuition. Admitted students who defer their admission are subject to the potentially higher tuition fees for incoming students effective at the later program start date. In case of a discrepancy between this webpage and the UBC Calendar, the UBC Calendar entry will be held to be correct.

Financial Support

Applicants to UBC have access to a variety of funding options, including merit-based (i.e. based on your academic performance) and need-based (i.e. based on your financial situation) opportunities.

Program Funding Packages

All students who secure a supervisor and who are enrolled in the program will be paid a minimum stipend of $30,000/year.

Funding Statistics

Based on the criteria outlined below, 46 students within this program were included in this study because they received funding through UBC in the form of teaching, research, academic assistantships or internal or external awards with a mean of $27,433 and a median of $33,392.

This results in a net balance (any funding provided to the student minus tuition and fees) mean of $19,268 and median of $25,105.

6 students received Teaching Assistantships. Median TA funding based on 6 students was $6,144.
21 students received Research Assistantships. Median RA funding based on 21 students was $28,600.
2 students received Academic Assistantships. Median AA funding based on 2 students was $15,189.
46 students received internal awards. Median internal award funding based on 46 students was $3,185.
6 students received external awards. Median external award funding based on 6 students was $30,000.

Study Period: Sep 2023 to Aug 2024 - funding for full-time PhD students enrolled in three terms per academic year in this program across years 1-4, the period covered by UBC's Minimum Funding Guarantee. Mean and median values might mask variability in sources and amounts of funding received by individual students. Beyond year 4, funding packages become even more individualized.
Review methodology

Scholarships & awards (merit-based funding)

All applicants are encouraged to review the awards listing to identify potential opportunities to fund their graduate education. The database lists merit-based scholarships and awards and allows for filtering by various criteria, such as domestic vs. international or degree level.

Graduate Research Assistantships (GRA)

Many professors are able to provide Research Assistantships (GRA) from their research grants to support full-time graduate students studying under their supervision. The duties constitute part of the student's graduate degree requirements. A Graduate Research Assistantship is considered a form of fellowship for a period of graduate study and is therefore not covered by a collective agreement. Stipends vary widely, and are dependent on the field of study and the type of research grant from which the assistantship is being funded.

Graduate Teaching Assistantships (GTA)

Graduate programs may have Teaching Assistantships available for registered full-time graduate students. Full teaching assistantships involve 12 hours work per week in preparation, lecturing, or laboratory instruction although many graduate programs offer partial TA appointments at less than 12 hours per week. Teaching assistantship rates are set by collective bargaining between the University and the Teaching Assistants' Union.

Graduate Academic Assistantships (GAA)

Academic Assistantships are employment opportunities to perform work that is relevant to the university or to an individual faculty member, but not to support the student’s graduate research and thesis. Wages are considered regular earnings and when paid monthly, include vacation pay.

Financial aid (need-based funding)

Canadian and US applicants may qualify for governmental loans to finance their studies. Please review eligibility and types of loans.

All students may be able to access private sector or bank loans.

Foreign government scholarships

Many foreign governments provide support to their citizens in pursuing education abroad. International applicants should check the various governmental resources in their home country, such as the Department of Education, for available scholarships.

Working while studying

The possibility to pursue work to supplement income may depend on the demands the program has on students. It should be carefully weighed if work leads to prolonged program durations or whether work placements can be meaningfully embedded into a program.

International students enrolled as full-time students with a valid study permit can work on campus for unlimited hours and work off-campus for no more than 24 hours a week during academic sessions.

A good starting point to explore student jobs is the UBC Work Learn program or a Co-Op placement.

Tax credits and RRSP withdrawals

Students with taxable income in Canada may be able to claim federal or provincial tax credits.

Canadian residents with RRSP accounts may be able to use the Lifelong Learning Plan (LLP) which allows students to withdraw amounts from their registered retirement savings plan (RRSPs) to finance full-time training or education for themselves or their partner.

Please review Filing taxes in Canada on the student services website for more information.

Cost Estimator

Applicants have access to the cost estimator to develop a financial plan that takes into account various income sources and expenses.

Career Outcomes

7 students graduated between 2005 and 2013: 1 is in a non-salaried situation; for 0 we have no data (based on research conducted between Feb-May 2016). For the remaining 6 graduates:

Sample Employers in Higher Education

Queen's University Belfast
University of Toronto

Sample Employers Outside Higher Education

Johnson and Johnson Inc.
Princess Margaret hospital
RepliCel Life Sciences Inc.
BC Cancer Agency

Sample Job Titles Outside Higher Education

Senior Scientist
Postdoctoral Fellow
Director
Staff Scientist

PhD Career Outcome Survey

You may view the full report on career outcomes of UBC PhD graduates on outcomes.grad.ubc.ca.

Disclaimer

These data represent historical employment information and do not guarantee future employment prospects for graduates of this program. They are for informational purposes only. Data were collected through either alumni surveys or internet research.

Career Options

Graduates have a wide range of options from working in government institutions to academia to biotechnology and bio-pharm companies. Those looking to further their academic career have are undertaking post-doctoral positions in Canada and abroad.

Enrolment, Duration & Other Stats

These statistics show data for the Doctor of Philosophy in Interdisciplinary Oncology (PhD). Data are separated for each degree program combination. You may view data for other degree options in the respective program profile.

ENROLMENT DATA

	2023	2022	2021	2020	2019
Applications	18	16	20	14	14
Offers	15	6	9	7	7
New Enrolment	14	5	6	6	6
Total Enrolment	66	56	51	42	40

Completion Rates & Times

This program has a graduation rate of 96% based on 25 students admitted between 2011 - 2014. Based on 8 graduations between 2020 - 2023 the minimum time to completion is 4.78 years and the maximum time is 6.83 years with an average of 5.79 years of study. All calculations exclude leave times.

Disclaimer

Admissions data refer to all UBC Vancouver applications, offers, new enrolment for each registration year, May to April, e.g. data for 2022 refers to programs starting in 2022 Summer and 2022 Winter session, i.e. May 1, 2022 to April 30, 2023. Data on total enrolment reflects enrolment in Winter Session Term 1 and are based on snapshots taken on November 1 of each registration year. Program completion data are only provided for datasets comprised of more than 4 individuals. Graduation rates exclude students who transfer out of their programs. Rates and times of completion depend on a number of variables (e.g. curriculum requirements, student funding), some of which may have changed in recent years for some programs.

Upcoming Doctoral Exams

Monday, 7 July 2025 - 12:00pm - 2264, Diamond Health Care Centre, 2775 Laurel St

Ainiah Rushdiana Raquib

Investigating the SS18::SSX Oncoprotein and Establishing its Interactors in Synovial Sarcoma Using Antibody-Based Approaches

Monday, 28 July 2025 - 1:30pm - Dorothy Lam Boardroom, BC Cancer Research Institute, 675 West 10th Avenue

MONA ORANGI

The Role of Innate Lymphoid Cells in Steatohepatitis and Liver Fibrosis

Research Supervisors

Supervision

Instructions regarding thesis supervisor contact for Doctor of Philosophy in Interdisciplinary Oncology (PhD)

All applicants need firm commitment from a supervisor prior to applying.

Advice and insights from UBC Faculty on reaching out to supervisors

These videos contain some general advice from faculty across UBC on finding and reaching out to a supervisor. They are not program specific.

This list shows faculty members with full supervisory privileges who are affiliated with this program. It is not a comprehensive list of all potential supervisors as faculty from other programs or faculty members without full supervisory privileges can request approvals to supervise graduate students in this program.

Aparicio, Samuel (Breast cancer, genome sequencing )
Bally, Marcel Bertran (Pancreas centre)
Baumbusch, Jennifer (long-term residential care, family caregiving, Intellectual Disability, nursing care of older adults )
Benard, Francois (Medical isotopes Radioisotopes Nuclear Medicine Cancer Imaging Molecular imaging of cancer Radionuclide therapy, Cancer division, radiology, pancreas centre)
Bennewith, Kevin (Oncology; Molecular Pathology & Cell Biology; Cancer research; Solid tumour microenvironment; Hypoxia; Metastasis research; Pre-metastatic niche; Targeting hypoxic tumour cells in therapy; Radiation biology)
Brooks-Wilson, Angela (Bioinformatics; Clinical oncology; Genetic medicine; Genomics; cancer families; cancer genetics; genetic susceptibility; human genetics; longevity; Super seniors)
Brown, Carolyn Janet (Epigenetics and epigenomics; Other basic medicine and life sciences; Gene regulation and expression; Genomics; Developmental genetics (including sex determination); Applied Genetics; Chromosomes: Structure / Organization; DNA methylation; Epigenetic control of gene expression; Gene Regulation and Expression; Genes escaping X-chromosome inactivation; Long non-coding RNAs; X-chromosome inactivation; XIST RNA)
Campbell, Kristin (Clinical oncology; Physical therapy; Rehabilitation medicine; Biomarkers; Breast Cancer; Exercise Physiology; oncology; physical function; Physiology; Quality of Life and Aging; rehabilitation)
Cherkasov, Artem (Drug design; Bioinformatics, Molecular modeling; Proteomics; Artificial intelligence; Antibiotics )
Collins, Colin (translational genomics where mathematics, genomics, computer science, and clinical science converge in diagnostics and therapeutics)
Cox, Michael (genetic testing, experiences of hereditary risk, social and ethical implications of genetics, interpersonal and family communication, qualitative research, narrative and story, Prostate cancer)
Daugaard, Mads (Cancer progression and metastasis; Mechanisms of carcinogenesis; Cancer Diagnosis and Detection; Cancer biology; Cancer diagnostics; Cancer therapy; Cell Signaling and Cancer; Cell Therapy of Cancer; Chemotherapy; DNA damage response pathways; glycobiology; Immunotherapy; Radiotherapy; Cell stress and Cancer; Cell stress signalling in cancer)
Dedhar, Shoukat (molecular biology, molecular biology as it relates to disease; developing new theraputics for cancer; how brain cells (neurons)make connections, therapeutics for cancer; molecular genetics and cancer; medical research, cancer, inflammatory diseases, cariovascular diseases, Cellular proteins, extracellular martrix, integrins, signal transduction, calreticulin, protein kinase, gene expression, cell differentiation)
Dong, Xuesen (Cancer progression and metastasis; Gene and molecular therapy; Prostate Cancer; Drug development; RNA splicing and Gene Regulation; Hormone Dependent Cancers; Endocrine Regulation)
Drew, Yvette
Evgin, Laura
Garnis, Catherine (Cancer biology; Tumor progression; Oral premalignant lesions; Head and neck cancer; RNA biology, microRNAs; Alternative splicing; Biomarkers)
Gleave, Martin (Infectious diseases, interdisciplinary oncology, prostate)
Haase, Kristen (Nursing, n.e.c.; oncology; Older Adults; Geriatric oncology; Health systems research; Mixed Methods Research; Qualitative research; Self-management; E-health)
Hieter, Philip (Molecular biology of eukaryotic chromosome transmission )
Hirst, Martin (Bioinformatics; Clinical oncology; Genomics; Immunology; Microbiology; Carcinogenesis; Cellular Differentiation; Epigenomics; Leukemia; Molecular Genetics)
Holt, Robert (Immunogenetics, Metagenomics - Infectious agents in Cancer, Cancer Genomes, Neurobiology, DNA Sequencing)
Howard, Fuchsia (health service needs of vulnerable, high-risk survivors of acute life-threatening illness, specifically, cancer survivors and survivors of critical illnesses; hereditary cancer prevention and risk management and psychosocial and ethnocultural factors that shape health and illness experiences)
Huntsman, David (hereditary cancer, molecular pathology, cancer biomarkers, Pancreas centre)
Jiang, Xiaoyan (Cancer drug development and therapeutics)

Pages

Doctoral Citations

A doctoral citation summarizes the nature of the independent research, provides a high-level overview of the study, states the significance of the work and says who will benefit from the findings in clear, non-specialized language, so that members of a lay audience will understand it.

Year	Citation
2025	Dr. Im studies a deadly form of leukemia carrying the EVI1 protein, which makes cells highly resistant to treatment. He discovered a target that boosts the release of death signals from mitochondria during treatment, nullifying this resistance. His findings present a vulnerability that could further be developed into a novel treatment approach.
2025	Dr. Kotapalli studied the function of an epigenetic modulator in luminal muscle invasive bladder cancer. Her research provided a deeper understanding of the molecular mechanisms critical for development of luminal MIBC. The findings of the research will guide development of new therapies for bladder cancer.
2025	Dr. Monjaras studies focused on tissue engineering to improve treatment for bladder cancer patients. He developed a tumor model as a tool for drug efficacy testing and transformed stem cells into cells that could potentially be used in organ regeneration. These findings he hopes lead to the improved quality life and outcomes for patients.
2025	Dr. Shenasa studied immune cells surrounding tumors to identify markers linked to patients’ responses to cancer treatments. She compared methods for detecting these immune markers, from standard tests to novel, cutting-edge techniques. Her work can help researchers optimize treatment options for cancer patients.
2025	Dr. Wang’s research has been focused on developing new radioactive drugs to help detect and treat cancer by targeting a protein called GRPR. These drugs are designed to reduce normal organ accumulations and to improve stability for better tumor detection and treatment. The best candidate from her study is now being tested in a clinical trial.
2025	Dr. Panahi investigated the molecular drivers of high-risk multiple myeloma, a challenging and currently incurable blood cancer. She developed a novel risk classification approach to better identify aggressive cases and support the development of more effective targeted therapies.
2025	Dr. Wang transformed the understanding of prostate cancer by identifying lineage-specific transcription factors and a three-phase progression model. Highlighting NFIX as a key regulator of tumor dormancy, this work paves the way for early intervention to control cancer within a patient’s lifespan—bringing a cancer no-fear world closer.
2024	Dr. Banville studied B cells in the context of the immune response to ovarian cancer. She defined tumour-associated B cell reactivity patterns and discovered novel target antigens. Her findings suggest multi-faceted roles for B cells in anti-tumour immunity which will ultimately guide the development of more effective cancer immunotherapies.
2024	Dr. Gopal studied how different signals are altered in blood cells and surrounding cells within the bone marrow of Myelodysplastic syndrome and Acute myeloid leukemia patients. The findings from this research lead to the identification of a potential new biomarker to predict therapy response.
2024	Dr. Fraser studied Transmembrane Protease, Serine-2, a human protein present in the airways that is exploited by coronaviruses and influenza viruses for efficient viral infection. He discovered a method to isolate this protein, determine its 3-dimensional molecular structure, and pioneer drug development campaigns for novel respiratory antivirals.

Pages

Sample Thesis Submissions

Further Information

Specialization

Interdisciplinary Oncology

Interdisciplinary Oncology offers advanced study and research in a variety of fields relating to oncology. The focus on interdisciplinarity is accomplished through a breadth of coverage in the following disciplines: molecular and cellular biology, genetics, biophysics, bioinformatics, pharmaceutical sciences, radiological sciences, immunology, socio-behavioural studies, and epidemiology.

UBC Calendar

https://vancouver.calendar.ubc.ca/faculties-colleges-and-schools/faculty-graduate-and-postdoctoral-studies/degree-programs/interdisciplinary-oncology

Program Website

https://www.iop.ca/phd-program

Faculty Overview

Faculty of Medicine

Academic Unit

Division of Medical Oncology

Program Identifier

Canadian Applicant Deadline

15 January 2027

International Applicant Deadline

15 December 2026

Departments/Programs may update graduate degree program details through the Faculty & Staff portal. To update contact details for application inquiries, please use this form.